![1 Reason Now is a Great Time to Buy Berkshire Hathaway [BRK.B] Stock](https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg)
Berkshire Hathaway sits on an all-time-high cash balance of nearly $382 billion as of end-Q3 2025, giving new CEO Greg Abel substantial optionality to buy stocks, acquire businesses, or deploy capital internationally and into tech — actions that could shift the conglomerate’s portfolio away from its Buffett-era composition. Despite shares trading over 10% below their H1 2025 peak, Buffett remains the largest shareholder and chair, has not sold stock, and the firm’s large cash cushion positions Berkshire defensively amid tariff risks and a still-hawkish Federal Reserve. The company’s ample free cash flow and recent large purchase of Alphabet stock signal potential strategic flexibility, though a dividend remains possible but unlikely in the near term.
Market structure: Berkshire’s $~382B cash hoard (Q3 2025) makes it a countercyclical winner — private businesses, mid-cap acquirers, distressed equity sellers and asset managers that underprice whole companies benefit if BRK shifts to M&A; direct competitors for deals (PE firms, activist buyers) are worse off. Pricing power shifts toward cash-rich corporates in a downturn: expect bid-ask spreads on privately negotiated M&A to compress and public-to-private premiums to rise 200–500bps. Cross-asset: a large Berkshire bid cycle would tighten credit spreads (banks lend to acquirers), lift equities on deal news, mildly steepen the curve if corporate supply surges, and reduce demand for Treasuries as cash reallocates to equities/real assets. Risk assessment: Tail risks include a major regulatory change (tariffs or anti-trust limits on mega-deals), a sharp equity sell-off that forces opportunistic buying at higher book multiples, or activist/legacy-management clashes that lead to value-destroying deals; probability medium but impact high. Immediate (days) volatility hinges on Q4 results and any announced buyback/dividend; short-term (weeks-months) depends on deal flow and market dips; long-term (yrs) depends on Abel’s capital allocation track record versus Buffett’s. Hidden dependency: significant exposure to US tariffs and insurance cycle losses could sap deployable cash if underwriting deteriorates. Trade implications: Direct play — establish a core 2–3% position in BRK.B within 0–4 weeks, layering on 5–10% dips, hold 12–36 months; hedge market beta with a SPY short or put protection. Options — sell cash-secured BRK.B puts 6–8% below spot with 3–6 month expiries to acquire stock cheap, or buy 12–24 month LEAPS calls 10–20% OTM for asymmetric upside. Sector rotation — favor conglomerates/insurers (BRK, TRV) and select tech (GOOGL) if Abel’s international/tech tilt accelerates. Contrarian angles: Consensus underprices two facts: (1) cash is optionality, not dead weight — a $50B opportunistic deployment could re-rate book value by 5–10% if done accretively; (2) the probability of a dividend is low but non-zero — even a one-time special dividend or $10–20B buyback would be catalytic. Historical parallel: BRK’s 2008–2010 cash deployments preceded multi-year outperformance; unintended consequence — pressure to deploy may lead to overpaying in H2–2026, so size positions with capital preservation in mind.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment